Glyburide · DIN 02350467 · 5 mg · tablet
General benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-08 — choose a marketed DIN from the same-category list.Discontinued April 8, 2026 · checked November 17, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-04-08 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-04-08 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Glyburide · DIN 02350467
Manufacturer: Sanis Health Inc.; listing date 2011-10-25
Health Canada: Cancelled post market since 2026-04-08 · brand GLYBURIDE · ATC A10BB01 GLIBENCLAMIDE · form Tablet · route Oral · ingredients GLYBURIDE 5 MG · company Sanis health inc · schedule Prescription
Glyburide: Formulary list price $0.06 per unit (the source does not state the unit; exact figure $0.0573). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02350467)
Source record
DIN 02350467: Glyburide
Raw flags: chronicUseMed=Y, insOH=Y, sec3=Y
Item: 682002004; group id 747; item number 1830; lccId None; manufacturer id SAI
Source form: Tab; strength: 5mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit); diabetes medication flag
Source prices (unrounded): $0.0573; ministry $0.0573
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02350467
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83567
Interchangeable products
Apo-Glyburide · DIN 01913662 · $0.0573
Diabeta · DIN 02224569 · not recorded
Teva-Glyburide · DIN 01913689 · $0.0573
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since April 8, 2026 — choose a marketed DIN from the same-category list.